Viral Envelope Proteins
"Viral Envelope Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.
Descriptor ID |
D014759
|
MeSH Number(s) |
D12.776.964.970.880
|
Concept/Terms |
Viral Envelope Proteins- Viral Envelope Proteins
- Proteins, Viral Envelope
- Virus Envelope Proteins
- Envelope Proteins, Virus
- Proteins, Virus Envelope
- Envelope Proteins, Viral
|
Below are MeSH descriptors whose meaning is more general than "Viral Envelope Proteins".
Below are MeSH descriptors whose meaning is more specific than "Viral Envelope Proteins".
This graph shows the total number of publications written about "Viral Envelope Proteins" by people in UAMS Profiles by year, and whether "Viral Envelope Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2022 | 0 | 3 | 3 | 2014 | 0 | 1 | 1 | 2010 | 1 | 0 | 1 | 2009 | 1 | 2 | 3 | 2008 | 1 | 0 | 1 | 2007 | 0 | 1 | 1 | 2006 | 2 | 4 | 6 | 2005 | 0 | 1 | 1 | 2004 | 1 | 2 | 3 | 2003 | 1 | 0 | 1 | 2002 | 2 | 0 | 2 | 2001 | 1 | 0 | 1 | 2000 | 1 | 0 | 1 | 1995 | 0 | 1 | 1 | 1994 | 1 | 1 | 2 | 1991 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Viral Envelope Proteins" by people in Profiles over the past ten years.
-
Mazouz S, Salinas E, B?dard N, Filali A, Khedr O, Swadling L, Abdel-Hakeem MS, Siddique A, Barnes E, Bruneau J, Grakoui A, Shoukry NH. Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects. PLoS Pathog. 2022 11; 18(11):e1010968.
-
Belote A, Reece S, Robinson S, Jensen H, CarlLee S, Clark M, Parnell S, Geels C, Newton J. Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting. Monoclon Antib Immunodiagn Immunother. 2022 Aug; 41(4):210-213.
-
Tang J, Novak T, Hecker J, Grubbs G, Zahra FT, Bellusci L, Pourhashemi S, Chou J, Moffitt K, Halasa NB, Schwartz SP, Walker TC, Tarquinio KM, Zinter MS, Staat MA, Gertz SJ, Cvijanovich NZ, Schuster JE, Loftis LL, Coates BM, Mack EH, Irby K, Fitzgerald JC, Rowan CM, Kong M, Flori HR, Maddux AB, Shein SL, Crandall H, Hume JR, Hobbs CV, Tremoulet AH, Shimizu C, Burns JC, Chen SR, Moon HK, Lange C, Randolph AG, Khurana S. Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C. Nat Commun. 2022 05 27; 13(1):2979.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|